Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

Saved in:

Bibliographic Details
Title:	Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.
Authors:	Siebert U (AUTHOR), Sroczynski G (AUTHOR), Aidelsburger P (AUTHOR), Rossol S (AUTHOR), Wasem J (AUTHOR), Manns MP (AUTHOR), McHutchison JG (AUTHOR), Wong JB (AUTHOR), Siebert, Uwe¹ (AUTHOR), Sroczynski, Gaby (AUTHOR), Aidelsburger, Pamela (AUTHOR), Rossol, Siegbert (AUTHOR), Wasem, Jürgen (AUTHOR), Manns, Michael P (AUTHOR), McHutchison, John G (AUTHOR), Wong, John B (AUTHOR)
Source:	PharmacoEconomics. 2009, Vol. 27 Issue 4, p341-354. 14p.
Database:	Academic Search Ultimate

Description
ISSN:	11707690
DOI:	10.2165/00019053-200927040-00006